肾透明细胞癌代谢失调及生物标志物的鉴定 - Suppr

Suppr

超能文献

Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma.

作者信息

Zheng Bin, Liu Kan, Ouyang Qing, Feng Ji, Cao Shouqing, Wang Li, Jia Tongyu, Wu ShengPan, Ma Xin, Zhang Xu, Li Xiubin

机构信息

Medical School of Chinese PLA, Beijing, China.

Department of Urology, The Third Medical Centre, Chinese PLA General Hospital, Beijing, China.

出版信息

Clin Transl Med. 2024 Dec;14(12):e70142. doi: 10.1002/ctm2.70142.

DOI:10.1002/ctm2.70142

PMID:39724511

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11670740/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cb1/11670740/e2097e518fba/CTM2-14-e70142-g001.jpg

相似文献

Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma.肾透明细胞癌代谢失调及生物标志物的鉴定

Clin Transl Med. 2024 Dec;14(12):e70142. doi: 10.1002/ctm2.70142.

miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.miRNA 谱分析在透明细胞肾细胞癌中的应用：生物标志物的发现以及 miRNA 失调的潜在调控和后果的鉴定。

J Urol. 2011 Sep;186(3):1077-83. doi: 10.1016/j.juro.2011.04.110. Epub 2011 Jul 23.

A Cluster of Metabolic-Related Genes Serve as Potential Prognostic Biomarkers for Renal Cell Carcinoma.一组代谢相关基因作为肾细胞癌潜在的预后生物标志物。

Front Genet. 2022 Jul 7;13:902064. doi: 10.3389/fgene.2022.902064. eCollection 2022.

Identification of DNA methylation patterns and biomarkers for clear-cell renal cell carcinoma by multi-omics data analysis.通过多组学数据分析鉴定透明细胞肾细胞癌的DNA甲基化模式和生物标志物。

PeerJ. 2020 Aug 3;8:e9654. doi: 10.7717/peerj.9654. eCollection 2020.

Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma.β-连环蛋白的失调是透明细胞肾细胞癌患者肿瘤学预后的独立预测指标。

J Urol. 2014 Jun;191(6):1671-7. doi: 10.1016/j.juro.2013.11.052. Epub 2013 Nov 26.

Immunobiology and Metabolic Pathways of Renal Cell Carcinoma.肾细胞癌的免疫生物学与代谢途径

Hematol Oncol Clin North Am. 2023 Oct;37(5):827-840. doi: 10.1016/j.hoc.2023.04.012. Epub 2023 May 26.

Non-coding transcriptome profiles in clear-cell renal cell carcinoma.透明细胞肾细胞癌中的非编码转录组图谱

Nat Rev Urol. 2025 Mar;22(3):151-174. doi: 10.1038/s41585-024-00926-3. Epub 2024 Sep 6.

Metabolic heterogeneity in clear cell renal cell carcinoma revealed by single-cell RNA sequencing and spatial transcriptomics.单细胞 RNA 测序和空间转录组学揭示透明细胞肾细胞癌中的代谢异质性。

J Transl Med. 2024 Feb 27;22(1):210. doi: 10.1186/s12967-024-04848-x.

Bioinformatics-driven identification of prognostic biomarkers in kidney renal clear cell carcinoma.生物信息学驱动的肾透明细胞癌预后生物标志物鉴定

Front Nephrol. 2024 Apr 4;4:1349859. doi: 10.3389/fneph.2024.1349859. eCollection 2024.

Identification of metabolism-associated genes and pathways involved in different stages of clear cell renal cell carcinoma.鉴定参与透明细胞肾细胞癌不同阶段的代谢相关基因和通路。

Oncol Lett. 2018 Feb;15(2):2316-2322. doi: 10.3892/ol.2017.7567. Epub 2017 Dec 8.

引用本文的文献

Gastric Cancer Treatment New Chapter: Organoid Models Leading Personalized Medicine.胃癌治疗新篇章：类器官模型引领个性化医疗。

Mol Diagn Ther. 2025 Sep 4. doi: 10.1007/s40291-025-00808-3.

Intervention of machine learning in bladder cancer research using multi-omics datasets: systematic review on biomarker identification.利用多组学数据集的机器学习在膀胱癌研究中的干预：生物标志物识别的系统评价

Discov Oncol. 2025 Jun 5;16(1):1010. doi: 10.1007/s12672-025-02734-6.

GAMT facilitates tumor progression via inhibiting p53 in clear cell renal cell carcinoma.甘氨酸-N-甲基转移酶（GAMT）通过抑制透明细胞肾细胞癌中的p53促进肿瘤进展。

Biol Direct. 2025 Apr 2;20(1):43. doi: 10.1186/s13062-025-00641-y.

本文引用的文献

Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression.对透明细胞肾细胞癌进行多组学分析，确定与疾病进展相关的代谢重编程。

Nat Genet. 2024 Mar;56(3):442-457. doi: 10.1038/s41588-024-01662-5. Epub 2024 Feb 15.

Inosine enhances tumor mitochondrial respiration by inducing Rag GTPases and nascent protein synthesis under nutrient starvation.肌苷在营养饥饿条件下通过诱导 Rag GTPases 和新生蛋白质合成来增强肿瘤线粒体呼吸。

Cell Death Dis. 2023 Aug 2;14(8):492. doi: 10.1038/s41419-023-06017-2.

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.组织病理学和蛋白质基因组学异质性揭示了透明细胞肾细胞癌侵袭性的特征。

Cancer Cell. 2023 Jan 9;41(1):139-163.e17. doi: 10.1016/j.ccell.2022.12.001. Epub 2022 Dec 22.

Antitumor Effects of L-citrulline on Hela Cervical Cancer Cell Lines.L-瓜氨酸对宫颈癌 Hela 细胞系的抗肿瘤作用。

Anticancer Agents Med Chem. 2022;22(18):3157-3162. doi: 10.2174/1871520622666220426101409.

Tobacco smoking induces metabolic reprogramming of renal cell carcinoma.吸烟可诱导肾细胞癌的代谢重编程。

J Clin Invest. 2021 Jan 4;131(1). doi: 10.1172/JCI140522.

Metabolomic adaptations and correlates of survival to immune checkpoint blockade.代谢组学适应和与免疫检查点阻断治疗生存相关的因素。

Nat Commun. 2019 Sep 25;10(1):4346. doi: 10.1038/s41467-019-12361-9.

The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.肾细胞癌的癌症基因组图谱：发现与临床意义。

Nat Rev Urol. 2019 Sep;16(9):539-552. doi: 10.1038/s41585-019-0211-5. Epub 2019 Jul 5.

Metabolic reprogramming in clear cell renal cell carcinoma.透明细胞肾细胞癌中的代谢重编程。

Nat Rev Nephrol. 2017 Jul;13(7):410-419. doi: 10.1038/nrneph.2017.59. Epub 2017 May 8.

Integrated transcriptomic and metabolomic analysis shows that disturbances in metabolism of tumor cells contribute to poor survival of RCC patients.整合转录组学和代谢组学分析表明，肿瘤细胞代谢紊乱导致 RCC 患者生存不良。

Biochim Biophys Acta Mol Basis Dis. 2017 Mar;1863(3):744-752. doi: 10.1016/j.bbadis.2016.12.011. Epub 2016 Dec 22.

An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌的综合代谢图谱

Cancer Cell. 2016 Jan 11;29(1):104-116. doi: 10.1016/j.ccell.2015.12.004.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验